Search results for lundbeck

Avatar Posted by worldpharmanews 686 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: lundbeck circadin
H. Lundbeck A/S and Neurim Pharmaceuticals Ltd. announced that Lundbeck has obtained expanded exclusive rights to commercialize Circadin® in Asia, Latin America and other major markets such as Austra read more »
Discuss   Add this link to...  Bury
Avatar Posted by worldpharmanews 568 days ago (http://www.worldpharmanews.com)
Category: Clinical Trials | Tags: adagio lundbeck
Lundbeck's partner Teva Pharmaceutical Industries Ltd. has announced that results of the phase III ADAGIO trial were presented during the 12th Congress of European Federation of Neurological Societi read more »
Discuss   Add this link to...  Bury
Avatar Posted by worldpharmanews 401 days ago (http://www.worldpharmanews.com)
Category: Financial | Tags: lundbeck ovation
H. Lundbeck A/S (Lundbeck) and Ovation Pharmaceuticals, Inc. (Ovation) today announced that they have entered into a definitive transaction agreement under which Lundbeck, through the wholly owned su read more »
Discuss   Add this link to...  Bury
Avatar Posted by worldpharmanews 378 days ago (http://www.worldpharmanews.com)
Category: Financial | Tags: lundbeck
Lundbeck has presented annual accounts in which all of the financial results meet the financial guidance announced by the company in March 2008. For the first time ever, revenue exceeded DKK 11 billi read more »
Discuss   Add this link to...  Bury
Avatar Posted by worldpharmanews 282 days ago (http://www.worldpharmanews.com)
Category: Clinical Trials | Tags: lu aa21004 lundbeck
H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) jointly have announced headline results from the first three clinical trials in the phase III development programme with read more »
Discuss   Add this link to...  Bury
Avatar Posted by worldpharmanews 265 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: serdolect lundbeck
H. Lundbeck A/S (LUN.CO; LUN DC) has received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) for Serdolect® (sertindole) for the treatment of schizophrenia. read more »
Discuss   Add this link to...  Bury
Avatar Posted by worldpharmanews 257 days ago (http://www.worldpharmanews.com)
Category: Clinical Trials | Tags: lundbeck lu aa24530
H. Lundbeck A/S (Lundbeck) today announced positive headline results from a dose finding clinical trial with the compound Lu AA24530 for the treatment of major depressive disorder (MDD). read more »
Discuss   Add this link to...  Bury
Avatar Posted by worldpharmanews 253 days ago (http://www.worldpharmanews.com)
Category: Corporate | Tags: lundbeck neuronicon
Through the acquisition of the Aarhus-based biotech company NeuronIcon, Lundbeck will gain ownership of technologies that may lead to a breakthrough in the treatment of brain damage following strokes read more »
1 Comment   Add this link to...  Bury
Avatar Posted by worldpharmanews 108 days ago (http://www.worldpharmanews.com)
Category: Clinical Trials | Tags: lundbeck ae58054
H. Lundbeck A/S announced the initiation of a multi-centre, placebo-controlled, fixed-dose study of Lu AE58054 as add-on to donepezil in patients with moderate Alzheimer's disease. The clinical phas read more »
Discuss   Add this link to...  Bury



News/Blogroll [ alliConnect | BioJobBlog | Central and Eastern Europe Pharma | CNTO411 | Corey Nahman | eDrugSearch | Drug Injury Watch | EyeOnFDA | Forbes ScienceBiz | Healthy Skepticism | JNJ BTW | medGadget | Medical 2.0 | Pharma's Market at CNBC | PharmaFraud | PharmaGossip | Pharmalot | PharmaNews.eu | Polish Pharma Market | The Shark Report | World Pharma News | WSJ Health Blog ]
Pharmaceutical Companies [ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

About | Buttons | Contact | Terms and Conditions
Concept and Design by World Pharma News (.com) Project | Powered by Pligg based on PHP/MySQL.
Submit to World Pharma News .net